Stay updated on PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.

Latest updates to the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedRecruitment status now shows the study is no longer enrolling participants, indicating enrollment is closed; the page also adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header along with a revision note to v3.6.0.SummaryDifference0.5%

- Check16 days agoChange DetectedThe page revision label updated from v3.5.4 to v3.5.5, indicating a newer page version; no study data or content changes are introduced.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page revision label has been updated to v3.5.4, replacing the previous v3.5.3 and signaling a small update to the page’s documentation/metadata.SummaryDifference0.1%

- Check58 days agoChange DetectedA page revision identifier was updated from **v3.5.2** to **v3.5.3**, reflecting an update to the site/version rather than any change to the clinical trial information.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check94 days agoChange DetectedThe site revision has been updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.1%

Stay in the know with updates to PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.